Target intelligence / Profile preview

Plasmodium falciparum heme polymerization complex (PfHPC)

Target
PfHPC
Molecular classification
Enzyme, Protein complex, Metabolic pathway component
01

Overview

The Plasmodium falciparum heme polymerization complex is a vital biochemical system responsible for the detoxification of free heme within the malaria parasite's digestive vacuole (Jani et al., 2008, PLoS Pathogens). During the intraerythrocytic stage of its life cycle, the parasite degrades host hemoglobin to obtain essential amino acids, a process that releases ferriprotoporphyrin IX (heme). Because free heme is highly toxic and can cause oxidative damage to membranes and proteins, the parasite converts it into an insoluble, inert crystalline polymer called hemozoin (Egan, 2008, J Inorg Biochem). This biocrystallization is facilitated by the Heme Detoxification Protein (HDP), which is considered one of the most efficient catalysts for this reaction (Jani et al., 2008, PLoS Pathogens). This pathway is the primary target for many classic antimalarial drugs, including chloroquine and quinine, which bind to heme or the growing crystal surface to inhibit further polymerization (Slater & Cerami, 1992, Nature). The resulting accumulation of toxic heme leads to the destruction of the parasite. However, the emergence of resistance, mediated by mutations in transporters like the P. falciparum chloroquine resistance transporter (PfCRT), remains a significant challenge in targeting this complex (NCBI, 2023).

Other names
Heme detoxification proteinHDPHemozoin formation complexHeme biocrystallization pathwayMalaria pigment formation complex
02

Mechanism of action

Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free heme (ferriprotoporphyrin IX) which causes parasite membrane damage and death (Slater & Cerami, 1992, Nature; Egan, 2008, J Inorg Biochem).

03

Biological functions

Heme detoxificationHemozoin synthesisHemoglobin metabolismBiocrystallization
04

Disease associations

InfectionMalaria
05

Safety considerations

Drug resistance (PfCRT and PfMDR1 mutations)QT interval prolongationRetinopathyNeuropsychiatric effects
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Hemozoin pigmentParasite lactate dehydrogenase (pLDH)Plasmodium falciparum histidine-rich protein 2 (PfHRP2)

Beyond the preview

Go deeper on Plasmodium falciparum heme polymerization complex (PfHPC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum heme polymerization complex (PfHPC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call